Precision cancer medicine is improved using novel statistical methods
A new set of statistical tools improve the ability to discover cancer drug biomarkers from cell lines, which are effective for tailoring drug treatments in… Read more »
Paul Geeleher & R. Stephanie Huang
Paul Geeleher is a postdoctoral scholar in the Department of Medicine at the University of Chicago. His interests are computational biology, cancer and pharmacogenomics.
R. Stephanie Huang is currently an Assistant Professor of Medicine; Member, Committee on Clinical Pharmacology and Pharmacogenomics, the University of Chicago Comprehensive Cancer Center, Center for Personalized Therapeutics, Committee on Cancer Biology at the University of Chicago. Her lab research focuses on translational pharmacogenomic research with particular interest in the pharmacogenomics of anticancer agents.
R. Stephanie Huang is currently an Assistant Professor of Medicine; Member, Committee on Clinical Pharmacology and Pharmacogenomics, the University of Chicago Comprehensive Cancer Center, Center for Personalized Therapeutics, Committee on Cancer Biology at the University of Chicago. Her lab research focuses on translational pharmacogenomic research with particular interest in the pharmacogenomics of anticancer agents.
Latest posts by Paul Geeleher & R. Stephanie Huang (see all)
- Precision cancer medicine is improved using novel statistical methods - 13th October 2016